Начало › Метастатичен рак › Вирджиния › Arlington
Клинични проучвания за Метастатичен рак в Arlington, VA
53 проучвания за Метастатичен рак търсят участници в обекти в и около Arlington (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Набиране на участнициФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 мили
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Набиране на участнициФаза 2
- Inova Fairfax Hospital, Falls Church · на 4 мили
- Inova Schar Cancer Institute, Fairfax · на 11 мили
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- Inova Schar Cancer Institute, Fairfax · на 11 мили
- NEXT Virginia, Fairfax · на 11 мили
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
Набиране на участнициФаза 1/2
- NEXT Oncology, Fairfax · на 11 мили
A Study of ASP3082 in Adults With Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · на 11 мили
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Набиране на участнициФаза 1
- ALX Center 2, Fairfax · на 11 мили
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Набиране на участнициФаза 2/3
- Virginia Cancer Specialists - Fairfax Office, Fairfax · на 11 мили
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Набиране на участнициФаза 3
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · на 11 мили
- Virginia Cancer Specialists, PC, Reston · на 14 мили
- и още 1
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 мили
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Набиране на участнициФаза 3
- Research Site, Fairfax · на 11 мили
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Набиране на участнициФаза 2
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology, Fairfax · на 11 мили
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Набиране на участнициФаза 1/2
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Набиране на участнициФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 мили
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Набиране на участнициФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 мили
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Набиране на участнициФаза 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · на 11 мили
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, PC, Fairfax · на 11 мили
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology, Fairfax · на 11 мили
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- USO-Virginia Cancer Specialists, PC, Fairfax · на 11 мили
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Набиране на участнициФаза 3
- USO - Virginia Cancer Specialists, Fairfax · на 11 мили
NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
Набиране на участнициФаза 1
- NEXT, Fairfax · на 11 мили
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Набиране на участнициФаза 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · на 11 мили
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Набиране на участнициФаза 2
- Inova Schar Cancer Institute, Fairfax · на 11 мили
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Набиране на участнициФаза 1/2
- Crinetics Study Site, Fairfax · на 11 мили
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Набиране на участнициФаза 3
- Research Site, Falls Church · на 4 мили
- Research Site, Fairfax · на 11 мили
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 мили
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of PYX-201 in Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study of LY4175408 in Participants With Advanced Cancer
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- Research Site, Fairfax · на 11 мили
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Набиране на участнициФаза 1
- Research Site, Fairfax · на 11 мили
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 мили
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
Набиране на участнициФаза 1/2
- NEXT Oncology, Fairfax · на 11 мили
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 мили
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Набиране на участнициФаза 1/2
- Next Oncology Virginia, Fairfax · на 11 мили
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
Набиране на участнициФаза 2/3
- Inova Schar Cancer, Fairfax · на 11 мили
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Набиране на участнициФаза 1
- NEXT Virigina, Fairfax · на 11 мили
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
Проучвания за Метастатичен рак в други градове
- Houston, TX104 проучвания
- New York City, NY93 проучвания
- Nashville, TN70 проучвания
- Boston, MA63 проучвания
- Los Angeles, CA57 проучвания
- St. Louis, MO54 проучвания
- Philadelphia, PA46 проучвания
- Chicago, IL45 проучвания
- San Antonio, TX44 проучвания
- Washington, DC43 проучвания
- Dallas, TX42 проучвания
- Seattle, WA39 проучвания
Други проучвания в Arlington
- Рак на белия дроб с недребноклетъчен тип104 проучвания
- Колоректален рак52 проучвания
- Рак (всички видове)48 проучвания
- Рак на гърдата47 проучвания
- Рак на яйчниците46 проучвания
- Рак на белия дроб41 проучвания
- Ендометриален рак39 проучвания
- Рак на панкреаса33 проучвания
- Плоскоклетъчен карцином на главата и шията26 проучвания
- Дребноклетъчен белодробен рак23 проучвания
- Рак на стомаха20 проучвания
- Тройно негативен рак на гърдата20 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.